South Korea will begin distributing the coronavirus vaccine developed by Novavax in February.
The drug safety ministry authorized the use of the two-dose protein-based vaccine by the U.S.-based biotechnology company earlier this month.
Jeong Eun-kyeong, commissioner of the Korea Disease Control and Prevention Agency, said in a regular press briefing Thursday that the vaccine is currently being manufactured by SK Bioscience in South Korea.
The unvaccinated will be given priority access to the shots, Jeong said.
Health experts are also discussing the possibility of using Novavax as the second dose for those who recieved other vaccines for their first shot.
Jeong added that related authorities are considering a fourth vaccine dose for immunocrompromised people.
Please send comments to firstname.lastname@example.org / copyright © tbs. Unauthorized redistribution prohibited.